Company Profile

Wound Care Innovations (WCI), a wholly owned subsidiary of Wound Management Technologies, Inc. (OTCBB:WNDM) was formed with the sole purpose of introducing and distributing a truly unique and innovative solution to the greater than $3.2 billion domestic US wound care market - CellerateRX®. WCI is the exclusive distributor of a line of ACTIVATED COLLAGEN™ wound care products featuring a patented molecular form of collagen called CellerateRX®. The Company's immediate market is with primary buyers including healthcare providers (physicians, clinics, hospitals, homecare, long term care and DME), and a vast secondary consumer market. WCI's line of Activated Collagen™-based products are all FDA cleared as medical devices and have been cleared for use in the management of chronic & acute wounds and skin ulcers.

Code of Ethics

WCI follows the ethics and health care compliance initiatives set forth by the AdvaMed Code of Ethics. These initiatives help make today's medical techonologies better, and tomorrow's health technologies a reality. The AdvaMed Code of Ethics can be found here (AdvaMed Code of Ethics).

Product Manufacturing

WCI procures its product, in finished form, from the manufacturer, Applied Nutritionals, LLC, our supplier and holder of the patent for the molecular form of our collagen.

Cleared by the FDA

CellerateRx® is a registered trademark of Applied Nutritionals, LLC Activated Collagen™ & CRXα™ are trademarks of Wound Care Innovations, LLC

CellerateRX Saves MoneyEvidence of CellerateRX Success

The Science





Training and Videos

White Papers


What is Collagen?

Information for your Doctor

Diabetic Ulcers

Ulcers due to Arterial Insufficiency

Pressure Ulcers

Surgical Wounds


Traumatic Wounds

Venous Stasis Ulcers

Superficial Wounds

Company Profile


WCI Newsletter


Contact Us

Press Release

Investors Information

In The News

Get Social

facebooktwitterlinkdinyou tube